HUMBER PRIMARY CARE — All Prescriptions & Medications — Page 9
Practice Code: B81006 | BRIDLINGTON, YO15 2QW
Showing results 401-450 of 741
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| RtS 2 - 2.4 kcal/ml m/sk lower volume with fibre (0913011) | 61 | 511.5K | £11.4K | +391.9% ▲ |
| 61 | 6,795 | £436 | -71.8% ▼ | |
| Tizanidine hydrochloride | 60 | 5,833 | £706 | +126.5% ▲ |
| Carmellose sodium | 60 | 2,520 | £321 | -7.4% ▼ |
| Umeclidinium bromide | 59 | 65 | £1.7K | -4.3% ▼ |
| Methylphenidate hydrochloride | 59 | 1,864 | £1.7K | -77.2% ▼ |
| Latanoprost and timolol | 59 | 540 | £874 | -22.7% ▼ |
| Cyproterone acetate | 58 | 1,960 | £2.6K | +428.3% ▲ |
| Rasagiline mesilate | 57 | 1,596 | £1.0K | +53.5% ▲ |
| Cabergoline | 57 | 456 | £1.0K | +267.6% ▲ |
| Aclidinium bromide/formoterol | 56 | 56 | £1.7K | +59.3% ▲ |
| Phenobarbital | 56 | 2,744 | £359 | +82.1% ▲ |
| Opicapone | 56 | 1,608 | £3.2K | +192.5% ▲ |
| Sodium feredetate | 56 | 23.7K | £675 | +95.5% ▲ |
| Ready to serve 2.4 kcal/ml milkshake higher volume (0913011) | 56 | 505.0K | £3.1K | +176.9% ▲ |
| Chlorhexidine gluconate | 56 | 24.0K | £165 | +155.0% ▲ |
| Indacaterol/glycopyrronium | 55 | 1,650 | £1.7K | +21.8% ▲ |
| Temazepam | 55 | 1,105 | £976 | -3.9% ▼ |
| Amantadine hydrochloride | 55 | 2,716 | £705 | +97.5% ▲ |
| Typhoid | 55 | 55 | £568 | -38.9% ▼ |
| 55 | 1,400 | £702 | +169.9% ▲ | |
| 55 | 3,940 | £13.7K | +46.3% ▲ | |
| Oestrogens conjugated | 54 | 3,444 | £1.2K | +164.5% ▲ |
| Mercaptopurine | 54 | 2,031 | £916 | +248.7% ▲ |
| Menthol | 54 | 20.2K | £743 | +91.8% ▲ |
| Terbinafine hydrochloride | 54 | 1,485 | £272 | +45.5% ▲ |
| 54 | 1,035 | £176 | +86.5% ▲ | |
| Chlorhexidine gluconate | 53 | 20.5K | £377 | +79.5% ▲ |
| 53 | 127 | £1.2K | +90.5% ▲ | |
| Betamethasone sodium phosphate | 52 | 3,692 | £489 | +322.9% ▲ |
| Diclofenac diethyl | 52 | 5,120 | £290 | -85.4% ▼ |
| Emollient bath and shower preparations | 52 | 34.6K | £402 | -17.2% ▼ |
| Aciclovir | 52 | 358 | £334 | +321.8% ▲ |
| 52 | 2,600 | £5.9K | +500.6% ▲ | |
| 52 | 356 | £311 | +400.5% ▲ | |
| 51 | 560 | £1.5K | +6.6% ▲ | |
| 51 | 2,700 | £5.8K | +260.4% ▲ | |
| Trihexyphenidyl hydrochloride | 50 | 3,444 | £168 | +76.3% ▲ |
| Diclofenac sodium | 50 | 2,600 | £1.9K | +108.6% ▲ |
| 50 | 444 | £484 | +60.5% ▲ | |
| Oxcarbazepine | 49 | 6,132 | £955 | +75.2% ▲ |
| Indometacin | 49 | 2,408 | £157 | +211.4% ▲ |
| Olmesartan medoxomil | 48 | 1,344 | £59 | -30.3% ▼ |
| 48 | 265 | £510 | +307.1% ▲ | |
| 47 | 5,350 | £502 | -0.5% vs avg | |
| Phosphates (Rectal) | 46 | 460 | £23.1K | +276.3% ▲ |
| Fluticasone furoate/vilanterol | 46 | 53 | £1.2K | -70.3% ▼ |
| Mefenamic acid | 46 | 2,312 | £426 | +1.8% vs avg |
| 46 | 71 | £9.1K | +28.8% ▲ | |
| 46 | 550 | £1.7K | +125.9% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.